# Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

> **NCT04009772** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 500 (estimated)

## Conditions studied

- Emergency Cesarean Section
- Infection Wound

## Interventions

- **DRUG:** Cefepime
- **DRUG:** Cefuroxime plus Metronidazole

## Key facts

- **NCT ID:** NCT04009772
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04009772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04009772, "Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04009772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*